Home > Boards > US Listed > Medical - Drugs >

Kitov Pharmaceuticals Hldgs L Sponsored ADR (KTOV)

KTOV RSS Feed
Add KTOV Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 3/27/2020 11:59:59 PM - Followers: 110 - Board type: Free - Posts Today: 0




Kitov Pharma (KTOV)

Market Cap: $16 Million
Cash $17 Million
Price: $1.44

Shares Out: 10.6 Million


Kitov Announces FDA Acceptance of NDA for KIT-302..........October 3, 2017
https://www.baystreet.ca/articles/research_reports/lifesci/Kitov100317.pdf

KIT-302 is a Treatment for Hypertension and Osteoarthritis Pain.
KIT-302 is a fixed dose combination drug comprised of the nonsteroidal anti-inflammatory drug (NSAID)celecoxib, and the well-known antihypertensive agent, amlodipine besylate. Celecoxib monotherapy often leads to hypertension, which if uncontrolled, can increase the risk of heart attack and stroke. KIT-302 is designed to provide a solution for physicians who avoid prescribing NSAIDs for osteoarthritis pain due to their hypertensive side effects. There is currently no single drug for the treatment of pain and hypertension, so, if approved, KIT-302 could be a unique product in the multibillion-dollar osteoarthritis market.

Expected Upcoming Milestones

¦Additional marketing agreements for the distribution of KIT-302
¦Q4 2017 – Top-line results from Phase III kidney function trial.
¦Q2 2018 – Expected FDA approval decision for KIT-302.




Presentation June 2017
http://kitovpharma.investorroom.com/download/KitovPresentation+June+2017+FINAL.pdf

KIT-302 is a combination drug that treats osteoarthritis pain and hypertension simultaneously

Primary efficacy endpoint achieved Lead drug candidate KIT-302 achieved its primary efficacy endpoint in a pivotal Phase III trial

Marketing potential Pipeline candidates address large, multi-billion dollar markets




Kitov Received a $2 Million Filing Waiver from FDA
http://kitovpharma.investorroom.com/news-releases?item=46

Kitov Pharmaceuticals Holdings Ltd. (NASDAQ: KTOV, TASE: KTOV), an innovative biopharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has granted Kitov a waiver related to the $2,038,100 New Drug Application (NDA 210045) filing fee for KIT-302. KIT-302 is Kitov's patented combination of Amlodipine Besylate-Celecoxib tablets, intended to treat osteoarthritis pain and hypertension simultaneously.

 

Products

Kitov’s current pipeline products, KIT-301 and KIT-302, are combination drugs that treat OA pain and HTN simultaneously. In December 2015, KIT-302 successfully achieved the primary efficacy endpoint for its Phase III clinical trial. In August 2016, the United States Patent Office issued a patent covering KIT-302.

Market

Of the 27 million Americans with OA, 50% also suffer from HTN, which is also a common side effect of stand-alone OA drugs. With no single medication currently treating both conditions, KIT-301 and KIT-302 are targeting this multi-billion dollar market.



Kitov Pharma’s Arthritis Drug Meets Main Goal in Late-Stage Study
http://jewishbusinessnews.com/2015/12/16/kitov-pharmas-arthritis-drug-meets-main-goal-in-late-stage-study/

“KIT-302 has the potential to address the multi-billion dollar market for the treatment of osteoarthritis pain and hypertension with one drug that reduces patients’ risk of suffering a heart attack or stroke, while also reducing cost for payers. There is currently no single medication on the market that treats both osteoarthritis pain and hypertension and thus, KIT-302 will be the only NSAID indicated both to treat pain and to reduce the risk of heart attack, stroke and death.”

Pain medications for osteoarthritis account for billions of dollars in annual sales globally. Most pain medications for osteoarthritis, including celecoxib which had global sales of $2.7 billion in 2014, are non-steroidal anti-inflammatory drugs (NSAIDs) which have the side effect of elevating blood pressure, and increasing the risk of heart attacks, strokes and death. Of the 27 million Americans who live with osteoarthritis, 13.5 million also suffer from hypertension, which also increases the risk of heart attack, stroke, and death.





Dec. 17, 2015 :  Kitov Pharmaceuticals Reports Additional Data from its Phase III Trial on the Beneficial Blood Pressure Effects of KIT-302
http://www.prnewswire.com/news-releases/kitov-pharmaceuticals-reports-additional-data-from-its-phase-iii-trial-on-the-beneficial-blood-pressure-effects-of-kit-302-300194664.html



November 20, 2015 : Kitov Pharmaceuticals Holdings Announces Pricing of U.S. Initial Public Offering and NASDAQ Listing
http://www.prnewswire.com/news-releases/kitov-pharmaceuticals-holdings-announces-pricing-of-us-initial-public-offering-and-nasdaq-listing-552301701.html



October 21, 2015 : Kitov Pharma Announces Completion of Patient Recruitment for the Phase III Clinical Trial for KIT-302
http://www.prnewswire.com/news-releases/kitov-pharma-announces-completion-of-patient-recruitment-for-the-phase-iii-clinical-trial-for-kit-302-535035241.html





 

KTOV
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
KTOV News: Statement of Ownership (sc 13g) 02/13/2020 11:24:34 AM
KTOV News: Report of Foreign Issuer (6-k) 02/11/2020 07:02:12 AM
KTOV News: Report of Foreign Issuer (6-k) 02/03/2020 08:21:29 AM
KTOV News: Report of Foreign Issuer (6-k) 01/27/2020 06:03:42 AM
KTOV News: Small Company Offering and Sale of Securities Without Registration (d) 01/21/2020 04:06:32 PM
PostSubject
#7065   Better link shows price target of $12 and WALL$TREET 03/27/20 11:59:59 PM
#7064   KTOV analysts rating is a buy https://www.marketbeat.com/stocks/NASDAQ/KTOV/pric WALL$TREET 03/27/20 10:44:44 PM
#7063   Agreed. Looks like someone had to cover and WALL$TREET 03/27/20 08:08:55 PM
#7062   Who cares... georgie18 03/27/20 06:51:26 PM
#7061   Clay is here to short the stock just FYI WALL$TREET 03/27/20 06:07:06 PM
#7060   Ok thanks for the cheap shares signal. WALL$TREET 03/27/20 06:05:33 PM
#7059   * * $KTOV Video Chart 03-27-2020 * * ClayTrader 03/27/20 05:45:02 PM
#7058   Filled the open gap at .35... georgie18 03/27/20 05:44:44 PM
#7057   Looks like .40 break coming... georgie18 03/27/20 05:44:00 PM
#7056   It’s rocketing after hours. Love it! Hope WALL$TREET 03/27/20 05:43:04 PM
#7055   Got back in at .33 extended hours. WALL$TREET 03/27/20 05:39:51 PM
#7054   38s going in AH artificialselecter 03/27/20 05:09:20 PM
#7053   KTOV...338s clearing here trying to fill the 35 georgie18 03/27/20 03:45:27 PM
#7052   Nice going KTOV, 3 days midastouch017 03/27/20 12:58:15 PM
#7051   SO you will be PAYING an ADR Fee fwb 03/27/20 09:52:01 AM
#7050   Don't be fooled by the FDA approval fwb 03/27/20 09:50:00 AM
#7049   KTOV...32 Clearing in pre market...open gap in the georgie18 03/27/20 07:11:00 AM
#7048   33% institutional ownership and 8% insider ownership as artificialselecter 03/26/20 08:08:14 PM
#7047   From yearly report: artificialselecter 03/26/20 08:00:05 PM
#7046   KTOV in @ 0.278. Technical and fundamental bounce artificialselecter 03/26/20 12:12:37 PM
#7045   Why? Fai 2 03/26/20 08:32:28 AM
#7044   $KTOV running WALL$TREET 03/26/20 07:25:10 AM
#7043   We shall see... georgie18 03/25/20 10:52:46 AM
#7042   Looks nice. Maybe after hours news? Inve$tor77 03/25/20 10:49:56 AM
#7041   KTOV...28s starting here...5 million plus volume which was georgie18 03/25/20 10:48:04 AM
#7040   Dose anyone know what is going on here? Y money 03/25/20 10:47:34 AM
#7039   KTOV...26...Psar flipped to a Bullish Buy Position...3.5 million georgie18 03/25/20 10:06:47 AM
#7038   Robust volume, nice uptick! midastouch017 03/25/20 10:01:02 AM
#7037   Looks good Y money 03/25/20 08:43:43 AM
#7036   KTOV...27s clearing here...strong pre market volume for this ticker... georgie18 03/25/20 08:01:05 AM
#7035   KTOV...26...Pre Market...Bullish Homing Pigeon Reversal Pattern formed on georgie18 03/25/20 06:22:22 AM
#7034   This should be the bottom. Heading up from here. Y money 03/24/20 02:07:01 PM
#7033   Kitov Pharma Provides Update on Planned U.S. Launch powerbattles 03/12/20 09:28:44 AM
#7032   * * $KTOV Video Chart 01-24-2020 * * ClayTrader 01/24/20 04:21:25 PM
#7031   Kitov Pharma Receives Notice of Intention to Grant fwb 01/24/20 09:49:01 AM
#7030   She’s alive!!!! zj3001 01/24/20 09:01:04 AM
#7029   $KTOV : Popping to $1.08 on European PATENT news makinezmoney 01/24/20 08:28:26 AM
#7028   Interesting news for KTOV in regards NT-219 midastouch017 01/24/20 08:19:59 AM
#7027   Not that I can remember. The boys on zj3001 01/14/20 04:31:16 PM
#7026   Isn’t a 7.5 million payment ( independent of noretreat 01/14/20 04:26:59 PM
#7025   There is no income besides possible milestone payments. zj3001 01/14/20 04:10:47 PM
#7024   Midas... what’s the issue? Their science looks noretreat 01/14/20 04:01:23 PM
#7023   Thanks noretreat 01/13/20 02:28:46 PM
#7022   I see. noretreat 01/13/20 02:28:35 PM
#7021   First opportunity to jump ship, and i'm out. midastouch017 01/13/20 01:33:54 PM
#7020   Meeting with Kitov this week. Three years to deal....realistic? noretreat 01/12/20 01:34:03 PM
#7019   KTOV on a blitz of PRs probably looking midastouch017 01/09/20 08:50:58 AM
#7018   Of course the most important item has to midastouch017 01/08/20 08:42:26 AM
#7017   Indeed....... Locke1 01/08/20 07:57:01 AM
#7016   KTOV looking good today. Still a long way midastouch017 01/08/20 07:55:37 AM
PostSubject